Biosig Technologies Inc (BSGM)

$0.41

-0.04

(-8.89%)

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $0.35
    $0.45
    $0.41
    downward going graph

    14.61%

    Downside

    Day's Volatility :22.1%

    Upside

    8.77%

    downward going graph
  • $0.20
    $0.55
    $0.41
    downward going graph

    50.98%

    Downside

    52 Weeks Volatility :63.25%

    Upside

    25.05%

    downward going graph

Returns

PeriodBiosig Technologies IncIndex (Russel 2000)
3 Months
-67.15%
0.0%
6 Months
-79.36%
0.0%
1 Year
-95.42%
0.0%
3 Years
-98.71%
-20.2%

Highlights

Market Capitalization
6.8M
Book Value
- $0.39
Earnings Per Share (EPS)
-3.12
PEG Ratio
0.0
Wall Street Target Price
6.0
Profit Margin
0.0%
Operating Margin TTM
-22742.86%
Return On Assets TTM
-447.8%
Return On Equity TTM
-5977.35%
Revenue TTM
27.0K
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
180.0%
Gross Profit TTM
242.0K
EBITDA
-24.0M
Diluted Eps TTM
-3.12
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.61
EPS Estimate Next Year
-0.89
EPS Estimate Current Quarter
-0.29
EPS Estimate Next Quarter
-0.13

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Biosig Technologies Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 1363.41%

Current $0.41
Target $6.00

Technicals Summary

Sell

Neutral

Buy

Biosig Technologies Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Biosig Technologies Inc
Biosig Technologies Inc
22.28%
-79.36%
-95.42%
-98.71%
-99.46%
Stryker Corporation
Stryker Corporation
-3.84%
5.16%
12.86%
24.25%
52.69%
Boston Scientific Corp.
Boston Scientific Corp.
-3.68%
21.48%
41.72%
68.89%
76.47%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
-34.8%
-18.49%
-34.85%
-45.17%
-15.86%
Abbott Laboratories
Abbott Laboratories
1.03%
-5.4%
-7.12%
-11.35%
20.75%
Medtronic Plc
Medtronic Plc
-1.99%
-9.34%
-13.21%
-38.74%
-23.49%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Biosig Technologies Inc
Biosig Technologies Inc
NA
NA
0.0
-0.61
-59.77
-4.48
NA
-0.39
Stryker Corporation
Stryker Corporation
38.91
38.91
2.92
11.95
0.19
0.07
0.01
50.33
Boston Scientific Corp.
Boston Scientific Corp.
63.22
63.22
1.8
2.37
0.09
0.05
NA
13.16
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
36.4
36.4
5.19
2.76
0.22
0.12
NA
12.35
Abbott Laboratories
Abbott Laboratories
33.84
33.84
5.99
4.66
0.15
0.06
0.02
22.31
Medtronic Plc
Medtronic Plc
28.97
28.97
1.52
5.2
0.07
0.04
0.04
38.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Biosig Technologies Inc
Biosig Technologies Inc
Buy
$6.8M
-99.46%
NA
0.0%
Stryker Corporation
Stryker Corporation
Buy
$129.7B
52.69%
38.91
16.03%
Boston Scientific Corp.
Boston Scientific Corp.
Buy
$114.3B
76.47%
63.22
12.05%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Buy
$52.4B
-15.86%
36.4
23.74%
Abbott Laboratories
Abbott Laboratories
Buy
$186.6B
20.75%
33.84
13.65%
Medtronic Plc
Medtronic Plc
Buy
$102.5B
-23.49%
28.97
11.36%

Insights on Biosig Technologies Inc

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 1.0K → 12.0K (in $), with an average increase of 45.8% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -4.56M → -6.04M (in $), with an average decrease of 16.2% per quarter

  • Vs BSX

    In the last 1 year, Boston Scientific Corp. has given 41.7% return, outperforming this stock by 137.1%

  • Vs BSX

    In the last 3 years, Boston Scientific Corp. has given 68.9% return, outperforming this stock by 167.6%

Institutional Holdings

  • PFG Investments, LLC

    0.70%
  • Vanguard Group Inc

    0.46%
  • BlackRock Inc

    0.40%
  • Geode Capital Management, LLC

    0.38%
  • HRT FINANCIAL LLC

    0.17%
  • State Street Corporation

    0.12%

Company Information

biosig technologies, inc. (otcqb: bsgm) is a medical device company that is developing a proprietary technology platform designed to greatly improve the $3 billion electrophysiology (ep) marketplace. led by a proven management team and a veteran, independent board of directors, minneapolis-based biosig is preparing to commercialize its pure ep system.

Organization
Biosig Technologies Inc
Employees
4
CEO
Mr. Frederick D. Hrkac
Industry
Health Technology

FAQs